seasonal influenza epidemiology forecast
DelveInsight’s ‘Seasonal Influenza- Epidemiology Forecast–2034’ report delivers an in-depth understanding of the Seasonal Influenza, historical and forecasted epidemiology as well as the Seasonal Influenza trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Geographies Covered
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
Study Period: 2021-2034
Seasonal Influenza Disease Understanding
Seasonal influenza is an acute viral infection that spreads easily from person to person, causing annual epidemics which peak during the winter in temperate regions of the world. There are four types of influenza viruses: influenza A, B, C, and D, but only influenza A and B viruses cause clinically important human disease and seasonal epidemics.
Seasonal influenza is caused by a novel variant that exhibits antigenicity that is distinct from the past strains due to accumulated mutations. While seasonal influenza (flu) viruses are detected year-round in the United States, flu viruses are most common during the fall and winter. Initially, nonspecific symptoms predominate, including fever, chills or frank shaking, headaches, myalgia (muscle pain), malaise (discomfort) and anorexia.
Seasonal Influenza Diagnosis
A diagnosis of influenza is made mostly on the basis of clinical presentation and epidemiological likelihood of infection. As influenza-like illness can be caused by many viruses, the gold standard laboratory tests used for influenza are viral culture and reverse transcription PCR (RT-PCR).
Continued in the report…..
Seasonal Influenza Epidemiology Perspective by DelveInsight
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Medical visits related to Seasonal Influenza, Total Hospitalized Cases of Seasonal Influenza, Type-specific Cases of Seasonal Influenza, and Influenza Vaccination Coverage in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2021 to 2034
Seasonal Influenza Detailed Epidemiology Segmentation
- In the assessment done by DelveInsight, the estimated total medical visits related to seasonal influenza in the 7MM were 11,235,325 in 2021.
- The highest total medical visits related to Seasonal Influenza were accounted by the US in 2021 (4,314,281 cases), which are expected to show a rise in the future.
- In the EU-5, in 2021, Italy had the highest medical visits related to seasonal influenza with 2,937,446 cases, followed by France with 1,977,533 cases in the same year. On the other hand, Spain had the lowest medical visits of seasonal influenza as 228,686 cases in 2021.
- In 2021, the total hospitalized cases of seasonal influenza was 173,227 in 7MM which are expected to increase by 2034.
- Type-specific cases of seasonal influenza were categorized into two types, Type A and Type B. The United States showed the highest cases of Type A compared to other 7MM countries. In 2021, the US, alone accounts for approximately 60% of total cases of Type A influenza.
- In 2021, the total vaccinated population estimated to be 366,474,828 in the 7MM. Highest vaccinated population was seen in the US.
- In Japan, 8,105 medical visits related to seasonal influenza were estimated in 2021, which are expected to decline during the forecasted period (2022-2034).
- During the peak year of COVID-19 pandemic, a steep decline in the cases of seasonal influenza was recorded throughout the 7MM. These cases are anticipated to rise again during the forecasted period (2022-2034).
Scope of the Report
- The report covers the descriptive overview of Seasonal Influenza, explaining its symptoms, grading, pathophysiology, and various diagnostic approaches.
- The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
- The report assesses the disease risk and burden of Seasonal Influenza.
- The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
Report Highlights
- 10-year forecast of Seasonal Influenza
- 7MM Coverage
- Total Medical visits related to Seasonal Influenza
- Total Hospitalized Cases of Seasonal Influenza
- Type-specific Cases of Seasonal Influenza
- Influenza Vaccination Coverage
Key Questions Answered
- What are the disease risk and burden of Seasonal Influenza?
- What is the historical Seasonal Influenza patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), and Japan?
- What would be the forecasted patient pool of Seasonal Influenza at the 7MM level?
- What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Seasonal Influenza?
- Out of the above-mentioned countries, which country would have the highest cases of Seasonal Influenza during the forecast period (2025-2034)?
- At what CAGR the population is expected to grow across the 7MM during the forecast period (2025-2034)?
Reasons to buy
The Seasonal Influenza report will allow the user to -
- Develop business strategies by understanding the trends shaping and driving the 7MM+ Seasonal Influenza epidemiology forecast.
- The Seasonal Influenza epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
- The Seasonal Influenza epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 10-year forecast period using reputable sources.
Key Assessments
- Patient Segmentation
- Disease Risk and Burden
- Risk of Disease by segmentation
- Factors driving growth in a specific patient population
1. Key Insights
2. Report Introduction
3. Seasonal Influenza Epidemiology Overview at a Glance
3.1. Patient Share (%) Distribution of Seasonal Influenza in 2021
3.2. Patient Share (%) Distribution of Seasonal Influenza in 2034
4. Executive Summary of Seasonal Influenza
5. Disease Background and Overview: Seasonal Influenza
5.1. Introduction
5.2. Structure Influenza Virus
5.3. Types of Influenza virus
5.4. Key Endpoints in Influenza A
5.5. Inter-species Transmission
5.6. Causes
5.7. Clinical Manifestations and Complications Associated With Influenza
5.8. Pathophysiology
5.9. Diagnosis
5.9.1. Diagnostic Algorithm
5.9.2. Diagnostic Guidelines
6. Epidemiology and Patient Population
6.1. Key Findings
6.2. Methodology of Epidemiology
6.3. Assumptions and Rationale: 7MM
6.4. Total Medical Visits Related to Seasonal Influenza in the 7MM
6.5. Total Hospitalized Cases of Seasonal Influenza in the 7MM
6.6. The United States
6.6.1. Total Medical visits related to Seasonal Influenza in the United States
6.6.2. Total Hospitalized Cases of Seasonal Influenza in the United States
6.6.3. Type-specific Cases of Seasonal Influenza in the United States
6.6.4. Influenza Vaccination Coverage in the United States
6.7. Major Five European Countries
6.7.1. Germany
6.7.1.1. Total Medical visits related to Seasonal Influenza
6.7.1.2. Total Hospitalized Cases of Seasonal Influenza
6.7.1.3. Type-specific Cases of Seasonal Influenza
6.7.1.4. Influenza Vaccination Coverage
6.7.2. France
6.7.2.1. Total Medical visits related to Seasonal Influenza
6.7.2.2. Total Hospitalized Cases of Seasonal Influenza
6.7.2.3. Type-specific Cases of Seasonal Influenza
6.7.2.4. Influenza Vaccination Coverage
6.7.3. Italy
6.7.3.1. Total Medical visits related to Seasonal Influenza
6.7.3.2. Total Hospitalized Cases of Seasonal Influenza
6.7.3.3. Type-specific Cases of Seasonal Influenza
6.7.3.4. Influenza Vaccination Coverage
6.7.4. Spain
6.7.4.1. Total Medical visits related to Seasonal Influenza
6.7.4.2. Total Hospitalized Cases of Seasonal Influenza
6.7.4.3. Type-specific Cases of Seasonal Influenza
6.7.4.4. Influenza Vaccination Coverage
6.7.5. The United Kingdom
6.7.5.1. Total Medical visits related to Seasonal Influenza
6.7.5.2. Total Hospitalized Cases of Seasonal Influenza
6.7.5.3. Type-specific Cases of Seasonal Influenza
6.7.5.4. Influenza Vaccination Coverage
6.8. Japan
6.8.1. Total Medical Visits related to Seasonal Influenza in Japan
6.8.2. Total Hospitalized Cases of Seasonal Influenza in Japan
6.8.3. Type-specific Cases of Seasonal Influenza in Japan
6.8.4. Influenza Vaccination Coverage in Japan
7. Patient Journey
8. Key Opinion Leaders’ Views
9. Appendix
9.1. Bibliography
9.2. Report Methodology
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
List of Tables:
List of Table
Table 1: Summary of Seasonal Influenza (2021-2034)
Table 2: Seasonal Influenza vs. Pandemic Flu
Table 3: Clinical Manifestations and Complications Associated With Influenza
Table 4: Advantages and disadvantages of influenza diagnostic tests
Table 5: Influenza Virus Testing Methods
Table 6: Total Medical Visits Related to Seasonal Influenza in the 7MM (2021-2034)
Table 7: Total Hospitalized Cases of Seasonal Influenza in the 7MM (2021-2034)
Table 8: Total Medical visits related to Seasonal Influenza in the United States (2021-2034)
Table 9: Total Hospitalized Cases of Seasonal Influenza in the US (2021-2034)
Table 10: Type-specific Cases of Seasonal Influenza in the US (2021-2034)
Table 11: Influenza Vaccination Coverage of Seasonal Influenza in the US (2021-2034)
Table 12: Total Medical visits related to Seasonal Influenza in the EU-5 (2021-2034)
Table 13: Total Medical visits related to Seasonal Influenza in Germany (2021-2034)
Table 14: Total Medical visits related to Seasonal Influenza in France (2021-2034)
Table 15: Total Medical visits related to Seasonal Influenza in Italy (2021-2034)
Table 16: Total Medical visits related to Seasonal Influenza in Spain (2021-2034)
Table 17: Total Medical visits related to Seasonal Influenza in the UK (2021-2034)
Table 18: Total Hospitalized Cases of Seasonal Influenza in Germany (2021-2034)
Table 19: Total Hospitalized Cases of Seasonal Influenza in France (2021-2034)
Table 20: Total Hospitalized Cases of Seasonal Influenza in Italy (2021-2034)
Table 21: Total Hospitalized Cases of Seasonal Influenza in Spain(2021-2034)
Table 22: Total Hospitalized Cases of Seasonal Influenza in the UK (2021-2034)
Table 23: Total Hospitalized Cases of Seasonal Influenza in the EU-5 (2021-2034)
Table 24: Type-specific Cases of Seasonal Influenza in Germany (2021-2034)
Table 25: Type-specific Cases of Seasonal Influenza in France (2021-2034)
Table 26: Type-specific Cases of Seasonal Influenza in Italy (2021-2034)
Table 27: Type-specific Cases of Seasonal Influenza in Spain (2021-2034)
Table 28: Type-specific Cases of Seasonal Influenza in the UK (2021-2034)
Table 29: Type-specific Cases of Seasonal Influenza in the EU-5 (2021-2034)
Table 30: Influenza Vaccination Coverage of Seasonal Influenza in Germany (2021-2034)
Table 31: Influenza Vaccination Coverage of Seasonal Influenza in France (2021-2034)
Table 32: Influenza Vaccination Coverage of Seasonal Influenza in Italy (2021-2034)
Table 33: Influenza Vaccination Coverage of Seasonal Influenza in Spain (2021-2034)
Table 34: Influenza Vaccination Coverage of Seasonal Influenza in the UK (2021-2034)
Table 35: Influenza Vaccination Coverage of Seasonal Influenza in the EU-5 (2021-2034)
Table 36: Total Medical visits related to Seasonal Influenza in Japan (2021-2034)
Table 37: Total Hospitalized Cases of Seasonal Influenza in Japan (2021-2034)
Table 38: Type-specific Cases of Seasonal Influenza in Japan (2021-2034)
Table 39: Influenza Vaccination Coverage of Seasonal Influenza in Japan (2021-2034)
List of Figures:
List of Figures
Figure 1: Clinical representation of seasonal influenza
Figure 2: Structure-Influenza virus
Figure 3: Human Seasonal Influenza Virus
Figure 4: Symptoms of Influenza
Figure 5: Symptoms and complications of influenza
Figure 6: Antigenic drift and antigenic shift.
Figure 7: Influenza antigenic shift and antigenic drift.
Figure 8: Standard Assessment Protocol in
Figure 9: Guide to use of influenza virus diagnostic tests in investigating outbreaks in institutional or other closed settings
Figure 10: Algorithm to assist in the interpretation of influenza testing results and clinical decision-making during periods when influenza viruses are circulating in the community
Figure 11: Algorithm to assist in the interpretation of influenza testing results and clinical decision-making during periods when influenza viruses are NOT circulating in the community
Figure 12: Total Medical Visits Related to Seasonal Influenza in the 7MM (2021-2034)
Figure 13: Total Hospitalized Cases of Seasonal Influenza in the 7MM (2021-2034)
Figure 14: Total Medical visits related to Seasonal Influenza in the United States (2021-2034)
Figure 15: Total Hospitalized Cases of Seasonal Influenza in the US (2021-2034)
Figure 16: Type-specific Cases of Seasonal Influenza in the US (2021-2034)
Figure 17: Influenza Vaccination Coverage of Seasonal Influenza in the US (2021-2034)
Figure 18: Total Medical visits related to Seasonal Influenza in the EU-5 (2021-2034)
Figure 19: Total Medical visits related to Seasonal Influenza in Germany (2021-2034)
Figure 20: Total Medical visits related to Seasonal Influenza in France (2021-2034)
Figure 21: Total Medical visits related to Seasonal Influenza in Italy (2021-2034)
Figure 22: Total Medical visits related to Seasonal Influenza in Spain (2021-2034)
Figure 23: Total Medical visits related to Seasonal Influenza in the UK (2021-2034)
Figure 24: Total Hospitalized Cases of Seasonal Influenza in Germany (2021-2034)
Figure 25: Total Hospitalized Cases of Seasonal Influenza in France (2021-2034)
Figure 26: Total Hospitalized Cases of Seasonal Influenza in Italy (2021-2034)
Figure 27: Total Hospitalized Cases of Seasonal Influenza in Spain (2021-2034)
Figure 28: Total Hospitalized Cases of Seasonal Influenza in the UK (2021-2034)
Figure 29: Total Hospitalized Cases of Seasonal Influenza in the EU-5 (2021-2034)
Figure 30: Type-specific Cases of Seasonal Influenza in Germany (2021-2034)
Figure 31: Type-specific Cases of Seasonal Influenza in France (2021-2034)
Figure 32: Type-specific Cases of Seasonal Influenza in Italy (2021-2034)
Figure 33: Type-specific Cases of Seasonal Influenza in Spain (2021-2034)
Figure 34: Type-specific Cases of Seasonal Influenza in the UK (2021-2034)
Figure 35: Type-specific Cases of Seasonal Influenza in the EU-5 (2021-2034)
Figure 36: Influenza Vaccination Coverage of Seasonal Influenza in Germany (2021-2034)
Figure 37: Influenza Vaccination Coverage of Seasonal Influenza in France (2021-2034)
Figure 38: Influenza Vaccination Coverage of Seasonal Influenza in Italy (2021-2034)
Figure 39: Influenza Vaccination Coverage of Seasonal Influenza in Spain (2021-2034)
Figure 40: Influenza Vaccination Coverage of Seasonal Influenza in the UK (2021-2034)
Figure 41: Influenza Vaccination Coverage of Seasonal Influenza in the EU-5 (2021-2034)
Figure 42: Total Medical visits related to Seasonal Influenza in Japan (2021-2034)
Figure 43: Total Hospitalized Cases of Seasonal Influenza in Japan (2021-2034)
Figure 44: Type-specific Cases of Seasonal Influenza in Japan (2021-2034)
Figure 45: Influenza Vaccination Coverage of Seasonal Influenza in Japan (2021-2034)
Figure 46: Patient Journey of Seasonal Influenza
